Search results

Skip to results

Area of interest

Type

Status

Last updated

Showing 2251 to 2265 of 7964 results

  1. Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer (Review of TA909) [ID6434]

    In development [GID-TA11570] Expected publication date: 18 September 2025

    Technology appraisal guidance
    In development

  2. SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)

    In development [GID-MT526] Expected publication date: TBC

    Medical technologies guidance
    In development

  3. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

      Status ...

    Medical technologies guidance
    Topic selection

  4. eXroid for internal haemorrhoids

      Status ...

    Medical technologies guidance
    Topic selection

  5. Respirasense

      Status ...

    Medical technologies guidance
    Topic selection

  6. Cyanoacrylate glue for hernia mesh fixation

      Status ...

    Medical technologies guidance
    Topic selection

  7. Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia

    Awaiting development [GID-MT599] Expected publication date: TBC

    Medical technologies guidance
    Awaiting development

  8. Speedboat Inject for endoscopic submucosal dissection of lower gastrointestinal lesions

    Awaiting development [GID-MT602] Expected publication date: TBC

    Medical technologies guidance
    Awaiting development

  9. The Sonata Treatment - Transcervical Radiofrequency Fibroid Ablation using Intrauterine Ultrasound

    Awaiting development [GID-MT603] Expected publication date: TBC

    Medical technologies guidance
    Awaiting development

  10. Arthrosamid for symptomatic treatment of knee osteoarthritis

      Status ...

    Medical technologies guidance
    Topic selection

  11. Managing common infections - antimicrobial prescribing guidelines

    In development [GID-NG10050] Expected publication date: TBC

    NICE guideline
    In development

  12. Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]

    Suggested remit: To appraise the clinical and cost effectiveness of treprostinil sodium within its marketing authorisation for treating chronic thromboembolic p...

    Technology appraisal guidance
    Topic selection

  13. Inolimomab (Leukotac) for acute Graft versus host disease (aGvHD) after Allo-HSCT [ID3923]

    Awaiting development [GID-TA10823] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Sparsentan for treating focal segmental glomerulosclerosis in people 8 years and over [ID3955]

    Awaiting development [GID-TA10867] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. PLX-PAD for treating muscle injury after arthroplasty for hip fracture in people 60 to 90 years [ID3989]

    Awaiting development [GID-TA10885] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development